Czech/SlovakiaCzech RepublicSlovakia

US Agri-Giant Awaits First TimeClearance for GM Seeds in Europe

16.09.2003

Prague - The Czech Ministry of Environment has postponed a decision on the application by US agriculture giant Monsanto Corp. for clearance for so-called 'Bt Maize' for commercial production until an expert commission gives its opinion. Monsanto, the world's largest supplier of GM seeds, is the first company to ask Czech authorities to approve commercial production of GM seeds - no European country has done this so far. The Bt Maize strain has the advantage of being toxic to the European corn borer, a common pest of the maize crop.
Currently Monsanto only grows this strain of maize experimentally in the Czech Republic at Branisovice, in South Moravia. The Czech Minister for the Environment Libor Ambrozek was originally expected to rule on the Monsanto application by the end of June but handed over the documents to the expert panel in July (see also page 36). According to government sources it is uncertain how long the commission could take to report back and when a final decision could be expected.
In the Czech Republic all food products containing GMOs must, according to new case-law since January 1, 2002, be cleared by the Ministry of Health. The products themselves must be labelled as “genetically modified” or containing “genetically-modified organisms”. More food made from genetically modified crops could be on the way following the July 2 decision of the European Parliament to drop its five-year ban on the introduction of new biotech products on the European Union (EU) market and allow GM foods into the EU as long as they are clearly labelled.
The Bt-toxin, a protein which is naturally expressed in the soil bacterium Bacillus thuringiensis, has the ability to destroy the intestinal wall of different varmints without harmfull side-effects for beneficial organisms. In humans most isoforms of Bt-toxin are non-toxic and digested very early in the gastro-intestinal tract. Only one Bt-toxin variant, called Cry9c, is suspected to cause allergic reactions. Back in September 2000 Cry9c-containing StarLinkTM corn by former Aventis CropScience caused a food scandal when it was found in the human food supply despite having been approved for animal feed use only.
Monsanto began field trials in the Czech Republic in August 2001 using herbizide resitant Roundup Ready wheat. While according to Czech media reports public support for the new technology was more widespread in the Czech Republic at that time than in other European countries, the Monsanto trial had aggravated the discussion. Especially Greenpeace objected to the trials. The environmentalists argued that Monsanto's wheat was likely to contaminate regular grown crops threatening the country's wheat export.

Czech/SlovakiaCzech RepublicSlovakia

24.09.2007

Prague/Norwood – The international clinical trial company Medpace Inc. (Norwood, USA) has acquired the Czech contract research organisation Monax s.r.o. (Prague) for an undisclosed sum. With the acquisition, which the firm...

Czech/SlovakiaCzech RepublicSlovakia

11.07.2007

Prague/Foster City – An oligonucleotide analogon, originally developed at the Institute of Organic Chemistry and Biochemistry (IOCB) at the Czech Academy of Sciences in Prague, has entered clinical testing as treatment for...

Czech/SlovakiaCzech RepublicSlovakia

17.05.2007

Prague/Leuven – The Czech Republic is lagging behind in applying the ten year-old European convention on Human rights and biomedicine, according to a new report from EuroGentest, an EU-funded Network of Excellence, which assesses...

Czech/SlovakiaCzech RepublicSlovakia

21.11.2006

BIOTEC 2006, the first international biotechnology conference and exhibition in Eastern Europe, held at the end of October, staged the official inauguration ceremony of the International Clinical Research Center (ICRC). The...

Czech/SlovakiaCzech RepublicSlovakia

16.09.2006

In order to keep track of developments and to promote network-creation, for both domestic-domestic and domestic-foreign cooperations the South Moravian Innovation Centre, Brno, has conducted the Czech Republic’s first...

Czech/SlovakiaCzech RepublicSlovakia

21.07.2006

Bratislava – In late-April, the Slovak government authorized field trials with genetically modified MON 810 maize at three undisclosed locations. The total area of the field trials is approximately 30 hectares. Although Slovakia...

Czech/SlovakiaCzech RepublicSlovakia

21.07.2006

Pruhonice – Biomass production is a promising alternative for the Czech Republic’s agricultural sector. Biomass could cover the annual domestic bio-energy demand of 250 PJ (predicted for 2030), and could be exported as bio-fuels...

Czech/SlovakiaCzech RepublicSlovakia

12.05.2006

Prague - The French pharma giant Sanofi-Aventis S.A. strengthened its generics business in Central and Eastern Europe (CEE) with a participation in the Czech generics producer Zentiva a.s. According to Sanofi-Aventis, the company...

Czech/SlovakiaCzech RepublicSlovakia

12.05.2006

Brno - The International Clinical Research Center (ICRC) in Brno, will collaborate with the renowned Mayo Clinic in Rochester, MN, to establish a clinical and research education center that meets the challenges of 21st-century...

Czech/SlovakiaCzech RepublicSlovakia

17.03.2006

Humpolec - A product derived from genetically modified potatos with altered starch composition poses no threat to human health, according to a European Food Safety Authority (EFSA) panel ruling.BASF Plant Science's GM potato,...

Displaying results 31 to 40 out of 70

< Previous 31-40 Next >

© 2007-2014 BIOCOM

http://www.european-biotechnology-news.com/nc/news/messages-archive/archive-czech-slovakia/browse/3/article/us-agri-giant-awaits-first-timeclearance-for-gm-seeds-in-europe.html

Events

All Events

Stock list

All quotes

TOP

  • ADDEX3.13 CHF4.68%
  • CO.DON3.15 EUR4.30%
  • BB BIOTECH146.25 EUR2.17%

FLOP

  • WILEX2.35 EUR-5.24%
  • SANTHERA89.15 CHF-3.10%
  • EVOTEC2.93 EUR-2.33%

TOP

  • SANTHERA89.15 CHF31.2%
  • CO.DON3.15 EUR26.0%
  • PAION3.01 EUR24.4%

FLOP

  • ADDEX3.13 CHF-22.3%
  • EVOTEC2.93 EUR-21.2%
  • MEDIGENE3.95 EUR-15.1%

TOP

  • SANTHERA89.15 CHF2117.7%
  • CO.DON3.15 EUR250.0%
  • PAION3.01 EUR189.4%

FLOP

  • CYTOS0.24 CHF-94.0%
  • MERCK KGAA67.67 EUR-40.6%
  • THERAMETRICS0.09 CHF-40.0%

No liability assumed, Date: 17.09.2014


Current issue

All issues

Product of the week

Products